.jpg)
Here's a link to this year's Tribute Flip Book:
FOR IMMEDIATE RELEASE
Financial support now available for healthcare premiums, deductibles, copays, coinsurance and incidental medical expenses
The Myasthenia Gravis Foundation of California received an invitation to participate in the MG Walk in Southern California in Los Angeles. We had a number of Board Members and Medical Advisory Board Members attend. The event was well attended and the positive outlook of the people there was contagious!
Dr. Francy Shu's presented this slide as part of her presentation at a patient meeting in Costa Mesa on Oct 15, 2017. It lists the medications should MG Patients to avoid. To see the slide, please click on the link above.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the U.S. Food and Drug Administration (FDA) has approved Soliris® (eculizumab) as a treatment for adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody-positive.
This week there was an article in the New York Times Magazine about an MG Patient.
This article was written by Deanna Power, Director of Outreach at Disability Benefits Help (www.disabilitybenefitscenter.org) DBH is an independent organization dedicated to helping people of all ages receive the disability benefits they need, or remain eligible for Social Securi
See photos of the 52nd Annual Founders Dinner - it was a great evening! If you would like an original size photo, please email dova@myasthenia-ca.org and she will be happy to email it to you!
Please click below to read the articles.
You can read the following articles in the Summer Newsletter
Despite it being my first year with myasthenia gravis, not knowing what was wrong with me and initially being misdiagnosed, I have been very lucky compared to some.
6055 E. Washington Blvd.
Suite #350
Los Angeles, California 90040
Phone: (323) 887-0056